IP Library Granted Patent US 11,618,898
Granted Patent B2
US 11,618,898 · App. 16/415,528 · Granted Apr 4, 2023

Compositions and methods for activating silent gene clusters

Inventors: Oliver Liu (San Francisco, CA); Jeffrey Hoon Kim (Berkeley, CA)
Assignee: Zymergen Inc.
C12N15/1072C12N7/00C12N15/63C12N15/76C12N2795/10042C12N2795/10043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,618,898
App. No.
16/415,528
Granted
Apr 4, 2023
Kind
B2
Abstract

The disclosure provides compositions and methods for producing natural products in microorganisms that are otherwise unexpressed, poorly expressed or poorly transcribed. In particular aspects, the disclosure provides compositions and methods for activating a silent gene or gene cluster with a bacteriophage and/or Streptomyces Antibiotic Regulatory Protein (SARP) transcription factor.

Claims (12)

1. A method of identifying native products in a population of bacterial cells comprising:

(a) infecting the population of bacterial cells with a plurality of recombinant bacteriophages, wherein the plurality of recombinant bacteriophages comprises a nucleotide sequence that encodes one or more bacterial transcription factors,

(b) identifying the native products produced by the population of bacterial cells,

(c) comparing the native products identified in step (b) to the native products produced from a control population of bacterial cells that has not been infected with a plurality of bacteriophages that comprises nucleotide sequence that encodes the one or more bacterial transcription factors, and

(d) identifying the native products not produced by the control population of bacterial cells when there is a difference between the native products identified in the population of bacterial cells and the control population of bacterial cells.

2. The method of claim 1 , wherein the native products are identified through performing chromatography on bacterial cell pellets, bacterial cell lysis supernatants, or culture medium utilized in the growth of the bacteria.

3. The method of claim 2 , wherein the chromatography is selected from liquid chromatography, gas chromatography, column chromatography, flash chromatography, size-exclusion chromatography, hydrophi lie interaction chromatography, ion exchange chromatography, and two-dimensional chromatography.

4. The method of claim 3 , wherein the liquid chromatography is UHPLC.

5. The method of claim 2 , wherein the chromatography is combined with mass spectrometry.

6. The method of claim 1 , wherein the one or more transcription factors are operably linked to one or more heterologous control sequences.

7. The method of claim 6 , wherein the population of bacterial cells is a member of phylum Actinobacteria.

8. The method of claim 6 , wherein the plurality of recombinant bacteriophages is selected from the group consisting of R4, ϕC31, ϕC62 , ϕBTI, SVI and ϕC43.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jul 1, 2022
From: PERCEPTIVE CREDIT HOLDINGS II, LP, AS ADMINISTRATIVE AGENT
To: ZYMERGEN INC.
Reel/Frame 060421/0533 →
PATENT SECURITY AGREEMENT Recorded Dec 26, 2019
From: ZYMERGEN INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 051425/0485 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2019
From: LIU, OLIVER; KIM, JEFFREY HOON
To: RADIANT GENOMICS, INC.
Reel/Frame 049336/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2019
From: RADIANT GENOMICS, INC.
To: ZYMERGEN INC.
Reel/Frame 049336/0701 →
Continuity (3)
Division 15167224 · May 27, 2016
Provisional Application 62168631 · May 29, 2015
Related Publication 20190270986A1 · Sep 5, 2019